Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of eflornithine in
combination with lomustine, compared to lomustine taken alone, in treating patients whose
anaplastic astrocytoma has recurred/progressed after radiation and temozolomide chemotherapy.